# Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

> **NCT04703166** · — · RECRUITING · sponsor: **Tulane University School of Medicine** · enrollment: 360 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Samsung Galaxy Watch Active2

## Key facts

- **NCT ID:** NCT04703166
- **Lead sponsor:** Tulane University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-08
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2025-04-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04703166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04703166, "Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04703166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*